Claria Logotype
sv
Contact
svenska
  • Technology
  • Strategy
  • Pipeline
  • Cannabis
  • Leadership
  • Investors
    • Financial Reports
    • Press releases
    • The share
      • Largest shareholders
      • Insiders
      • Change in Share capital
      • Dividend policy
      • Risk factors
    • Corporate Governance
      • Board of Directors
      • Management and auditors
      • Articles of association
    • Company Description
    • Calendar
    • Certified Adviser
    • Important information about First North
    • Presentationer
  • Press
    • Images
    • Subscribe
    • Videos
  • Contact
  • /
  • Investors
  • /
  • Financial Reports
  • Financial Reports
  • Press releases
  • The share
    • Largest shareholders
    • Insiders
    • Change in Share capital
    • Dividend policy
    • Risk factors
  • Corporate Governance
    • Board of Directors
    • Management and auditors
    • Articles of association
  • Company Description
  • Calendar
  • Certified Adviser
  • Important information about First North
  • Presentationer

Financial Reports

Annual reports and interim reports will be available for download here. 305547-klarias financial year runs from 1 Januari–31 December. Interim Reports are published February, May, August and November.

  • 12 May 2022

    Klaria Interim Report Q1 2022

    Klaria Interim Report Q1 2022

  • 25 March 2022

    Klaria Annual Report 2021

    Summary of the year

  • 10 February 2022

    Klaria Year-End Report Q4 2021

    Klaria Year-End Report Q4 2021

  • 28 October 2021

    Klaria Interim Report Q3 2021

    Summary of the interim report

  • 19 August 2021

    Klaria Interim Report Q2 2021

    Klaria Interim Report Q2 2021

  • 14 May 2021

    Klaria Interim Report Q1 2021

    Klaria Interim Report Q1 2021

  • 29 January 2021

    Klaria Year-End Report Q4 2020

    Summary of the year-end report

  • 26 November 2020

    Klaria Interim Report Q3 2020

    Klaria Interim Report Q3 2020

  • 28 May 2020

    Klaria Interim Report Q1 2020

    Klaria Interim Report Q1 2020

  • 28 February 2020

    Klaria Pharma Holding Year-End Report

    Additions to the management team and structural changes to prepare for an increased focus on clinical development and out-licensing

 

Subscribe





We are using cookies to optimize your browsing experience. By continuing your browsing you consent to such use.


Read more
I understand

Contact

Virdings Allé 2
754 50 Uppsala
Sweden

+46 (0)8 446 42 99

[email protected]

Cookie policy
© Copyright 2022 – Klaria